{"title":"不良临床事件报告","authors":"J. Dill","doi":"10.1177/0069477020932561","DOIUrl":null,"url":null,"abstract":"A case/noncase disproportionality analysis report using data from VigiBase (1968-2016) evaluated the cases of sialorrhea associated with the use of antipsychotics. Cases of “salivary hypersecretion” were considered cases, and those with other adverse events were defined as noncases. A total of 1 169 254 drug-adverse drug reaction pairs from 425 304 unique Individual Case Safety Reports were identified. Sialorrhea was more frequently reported with clozapine (n = 2732 [1.1%]) compared with other antipsychotics (n = 2911 [0.31%]; reporting odds ratio = 3.60; 95% confidence interval = 3.41-3.79). In addition, sialorrhea was also reported relatively more often by consumers (reporting odds ratio = 19.8; 95% confidence interval = 15.1-25.9) compared with health care professionals (reporting odds ratio = 2.44; 95% confidence interval = 2.272.63). Based on the results of this disproportionality analysis report, the authors concluded that sialorrhea was reported almost 4 times more often with clozapine use than with other antipsychotic use and was reported 8 times more often by patients than by health care professionals. Clozapine [Clozapine] Man WH et al (ER Heerdink, Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, PO Box 80.082, 3508 TB Utrecht, Netherlands; e-mail: E.R.Heerdink@uu.nl) Reporting patterns of sialorrhea comparing users of clozapine to users of other antipsychotics: a disproportionality analysis using VigiBase. J Clin Psychopharmacol 40:283–286 (May) 2020","PeriodicalId":102871,"journal":{"name":"Clin-Alert®","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reporting on Adverse Clinical Events\",\"authors\":\"J. Dill\",\"doi\":\"10.1177/0069477020932561\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A case/noncase disproportionality analysis report using data from VigiBase (1968-2016) evaluated the cases of sialorrhea associated with the use of antipsychotics. Cases of “salivary hypersecretion” were considered cases, and those with other adverse events were defined as noncases. A total of 1 169 254 drug-adverse drug reaction pairs from 425 304 unique Individual Case Safety Reports were identified. Sialorrhea was more frequently reported with clozapine (n = 2732 [1.1%]) compared with other antipsychotics (n = 2911 [0.31%]; reporting odds ratio = 3.60; 95% confidence interval = 3.41-3.79). In addition, sialorrhea was also reported relatively more often by consumers (reporting odds ratio = 19.8; 95% confidence interval = 15.1-25.9) compared with health care professionals (reporting odds ratio = 2.44; 95% confidence interval = 2.272.63). Based on the results of this disproportionality analysis report, the authors concluded that sialorrhea was reported almost 4 times more often with clozapine use than with other antipsychotic use and was reported 8 times more often by patients than by health care professionals. Clozapine [Clozapine] Man WH et al (ER Heerdink, Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, PO Box 80.082, 3508 TB Utrecht, Netherlands; e-mail: E.R.Heerdink@uu.nl) Reporting patterns of sialorrhea comparing users of clozapine to users of other antipsychotics: a disproportionality analysis using VigiBase. J Clin Psychopharmacol 40:283–286 (May) 2020\",\"PeriodicalId\":102871,\"journal\":{\"name\":\"Clin-Alert®\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clin-Alert®\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/0069477020932561\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clin-Alert®","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0069477020932561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A case/noncase disproportionality analysis report using data from VigiBase (1968-2016) evaluated the cases of sialorrhea associated with the use of antipsychotics. Cases of “salivary hypersecretion” were considered cases, and those with other adverse events were defined as noncases. A total of 1 169 254 drug-adverse drug reaction pairs from 425 304 unique Individual Case Safety Reports were identified. Sialorrhea was more frequently reported with clozapine (n = 2732 [1.1%]) compared with other antipsychotics (n = 2911 [0.31%]; reporting odds ratio = 3.60; 95% confidence interval = 3.41-3.79). In addition, sialorrhea was also reported relatively more often by consumers (reporting odds ratio = 19.8; 95% confidence interval = 15.1-25.9) compared with health care professionals (reporting odds ratio = 2.44; 95% confidence interval = 2.272.63). Based on the results of this disproportionality analysis report, the authors concluded that sialorrhea was reported almost 4 times more often with clozapine use than with other antipsychotic use and was reported 8 times more often by patients than by health care professionals. Clozapine [Clozapine] Man WH et al (ER Heerdink, Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, PO Box 80.082, 3508 TB Utrecht, Netherlands; e-mail: E.R.Heerdink@uu.nl) Reporting patterns of sialorrhea comparing users of clozapine to users of other antipsychotics: a disproportionality analysis using VigiBase. J Clin Psychopharmacol 40:283–286 (May) 2020